Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
NGNE · NASDAQ · Pharmaceutical Preparations
$22.15−0.78 (−3.40%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Neurogene (NGNE) · oqro.io/stocks/NGNE · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
BALYASNY ASSET MANAGEMENT L.P. cut its NGNE stake below 5% (1.5%)Source5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Julian C. Baker cut its NGNE stake below 5% (5.0%)Source5%+ stake · Stake as of Sep 30, 2026 · Filed Oct 7, 2026
PRUDENTIAL FINANCIAL INC now owns 11.2% of NGNE as a passive investorSource5%+ stake · Stake as of Sep 30, 2026 · Filed Oct 6, 2026
Jennison Associates LLC now owns 11.1% of NGNE as a passive investorSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
RTW Investments, LP disclosed an increased position in NGNE for Q2 2025SourceInsider trade · Traded May 14, 2025 · Filed May 15, 2025
Officer sold ~$103K of NGNE shares in the open marketSourceInsider trade · Traded Mar 13, 2025 · Filed Mar 17, 2025
CFO sold ~$76K of NGNE shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Siren, L.L.C. no longer reported NGNE for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
RTW Investments, LP disclosed an increased position in NGNE for Q4 2024SourceInsider trade · Traded Nov 26, 2024 · Filed Nov 27, 2024
10% owner purchased ~$517K of NGNE shares in the open marketSourceInsider trade · Traded Nov 26, 2024 · Filed Nov 27, 2024
10% owner purchased ~$407K of NGNE shares in the open marketSourceInsider trade · Traded Nov 26, 2024 · Filed Nov 27, 2024
10% owner purchased ~$281K of NGNE shares in the open marketSourceInsider trade · Traded Nov 26, 2024 · Filed Nov 27, 2024
10% owner purchased ~$55K of NGNE shares in the open marketSourceInsider trade · Traded Nov 22, 2024 · Filed Nov 26, 2024
CFO purchased ~$491K of NGNE shares in the open marketSourceInsider trade · Traded Nov 22, 2024 · Filed Nov 26, 2024
CEO purchased ~$969K of NGNE shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
RTW Investments, LP disclosed an increased position in NGNE for Q3 2024Source